Disclosure Panels Details Page
Melanoma Panel - Disclosures as of 09/14/2018
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mark Albertini MD | Apeiron Biologics, Vienna, Austria Bristol-Myers Squibb Company |
None | None | None | ✔ |
| Alain Algazi MD | Acerta Pharma Amgen Inc. AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Celldex Therapeutics Genentech, Inc. Incyte Corporation MedImmune Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Oncosec Plexxikon |
Array Oncosec Valitor |
None | None | - |
| Christopher Barker MD | Amgen Inc. Bristol-Myers Squibb Company Elekta Merck & Co., Inc. University California San Francisco University of Florida Health Cancer Center Orlando |
Pfizer Inc. | None | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| William Carson III MD | None | None | None | None | ✔ |
| Daniel Coit MD, FACS | None | None | None | None | ✔ |
| Carlo Contreras MD | NA | NA | NA | NA | ✔ |
| Alycia Corrigan | None | None | None | None | - |
| Gregory Daniels MD, PhD | Bristol-Myers Squibb Company Eisai Inc. Iovance Merck & Co., Inc. |
None | Array Biopharmaceuticals sanofi-aventis U.S. |
None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | Decision Resources Group Consulting | None | None | - |
| Dominick DiMaio MD | None | None | None | None | - |
| Anita Engh PhD | None | None | None | None | - |
| Ryan Fields MD | None | None | None | None | ✔ |
| Martin Fleming MD, FACS | None | None | None | None | ✔ |
| Morganna Freeman DO | NA | NA | NA | NA | - |
| Anjela Galan MD | None | None | None | None | - |
| Brian Gastman MD | AbbVie, Inc. Merck & Co., Inc. |
AMD-Serrano | Castle Biosciences Merck & Co., Inc. quest imaging |
None | ✔ |
| Rene Gonzalez MD | Amgen Inc. Array BioPharma Boston Biomedical Bristol-Myers Squibb Company CheckMate Pharmaceuticals Dynavax Technologies Genentech, Inc. Hoffman-LaRoche Immunocore Iovance Merck & Co., Inc. Millennium Pharmaceuticals, Inc. Morphotek Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation Polynoma LLC Prometheus Reata Pharmaceuticals Regeneron Pharmaceuticals, Inc. Syndax Taiga Takeda Pharmaceuticals North America, Inc. TESARO, Inc. |
Bristol-Myers Squibb Company Genentech, Inc. Incyte Corporation NewLink Genetics Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | - |
| Valerie Guild MBA | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Douglas Johnson MD, MSCI | None | Array Biopharma Bristol-Myers Squibb Company Incyte Merck & Co., Inc. |
None | None | ✔ |
| Richard Joseph MD | None | Bristol-Myers Squibb Company Incyte Janssen Pharmaceutica Products, LP Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Julie Lange MD, ScM | None | None | None | None | ✔ |
| Miguel Materin MD | None | Castle Bioscience Expert witness Trial case |
None | None | - |
| Nicole McMillian MS | None | None | None | None | - |
| Sameer Nath MD | None | None | None | None | - |
| Anthony Olszanski MD, RPh | None | Array Bristol-Myers Squibb Company Merck & Co., Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Patrick Ott MD, PhD | None | Bristol-Myers Squibb Company Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Aparna Priyanath Gupta MD | None | None | None | None | - |
| Kumar Rao MD | Castle Bioscience | Castle Bioscience | None | None | - |
| Ramesh Rengan MD, PhD | None | None | None | None | - |
| Merrick Ross MD | None | Amgen Inc. CastleBiosciences Merck & Co., Inc. Provectus Pharmaceuticals |
Amgen Inc. CastleBiosciences Merck & Co., Inc. Provectus Pharmaceuticals |
None | ✔ |
| April Salama MD | Bristol-Myers Squibb Company Celldex Therapeutics Dynavax Genentech, Inc. Immunocore Incyte Corporation Merck & Co., Inc. Reata Pharmaceuticals |
Array Biocryst Merck & Co., Inc. |
Bristol-Myers Squibb Company | None | ✔ |
| Jack Skinner PhD | None | None | None | None | - |
| Joseph Skitzki MD | None | None | None | None | - |
| Jeffrey Sosman MD | None | Array Pharma Bristol-Myers Squibb Company Genentech, Inc. Incyte |
None | None | ✔ |
| Susan Swetter MD | None | None | None | None | ✔ |
| Kenneth Tanabe MD | NIH/DCP Phase I clinical trial of oncolytic virus |
Advance Medical Best Doctors Department of Defense, CDMRP Helix12 LEK Consulting UpToDate |
None | None | - |
| John Thompson MD | Calithera Celldex Therapeutics |
AstraZeneca Pharmaceuticals LP Boehringer Ingelheim GmbH |
None | None | - |
| Erin Vidic | None | None | None | None | - |
| Evan Wuthrick MD | None | None | None | None | ✔ |